COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-31
DOI
10.3389/fpsyt.2019.00375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
- (2019) O. Köhler‐Forsberg et al. ACTA PSYCHIATRICA SCANDINAVICA
- Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid
- (2019) Monica Feliz R. Castillo et al. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH
- Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study
- (2018) Sophie E. Holmes et al. BIOLOGICAL PSYCHIATRY
- Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
- (2018) Jonathan B. Savitz et al. Translational Psychiatry
- New drug candidates for depression - a nationwide population-based study
- (2018) L. V. Kessing et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited
- (2017) Chris Walker et al. POSTGRADUATE MEDICINE
- Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
- (2017) Alexandre K Wang et al. SCHIZOPHRENIA BULLETIN
- High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib
- (2017) Daniela Krause et al. Frontiers in Psychiatry
- Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review
- (2017) Livia J. De Picker et al. Frontiers in Psychiatry
- Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report
- (2017) Tsuyoshi Miyaoka et al. Frontiers in Psychiatry
- Sirukumab: A Potential Treatment for Mood Disorders?
- (2016) Aileen J. Zhou et al. ADVANCES IN THERAPY
- The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study
- (2016) Ole Köhler et al. AMERICAN JOURNAL OF PSYCHIATRY
- Concomitant NSAID use during antipsychotic treatment and risk of 2-year relapse – a population-based study of 16,253 incident patients with schizophrenia
- (2016) Ole Köhler et al. EXPERT OPINION ON PHARMACOTHERAPY
- Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain
- (2016) Nick Goeden et al. JOURNAL OF NEUROSCIENCE
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
- (2016) N Kappelmann et al. MOLECULAR PSYCHIATRY
- Schizophrenia risk from complex variation of complement component 4
- (2016) Aswin Sekar et al. NATURE
- Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress
- (2015) Chun Yang et al. ACTA NEUROPSYCHIATRICA
- Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression
- (2015) Jian-jun Yang et al. BIOLOGICAL PSYCHIATRY
- Peripheral IL-6 signaling: a promising therapeutic target for depression?
- (2015) Chun Yang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
- (2015) Valeria Mondelli et al. SCHIZOPHRENIA BULLETIN
- Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis
- (2015) Annamaria Cattaneo et al. Frontiers in Cellular Neuroscience
- Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress
- (2015) Chun Yang et al. ACTA NEUROPSYCHIATRICA
- Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes
- (2015) Elaine Setiawan et al. JAMA Psychiatry
- Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling
- (2014) I E Sommer et al. BONE MARROW TRANSPLANTATION
- Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab
- (2014) L. Traki et al. CLINICAL RHEUMATOLOGY
- Targeting classical IL-6 signalling or IL-6trans-signalling in depression?
- (2014) Michael Maes et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Adjunctive Recombinant Human Interferon Gamma-1b for Treatment-Resistant Schizophrenia in 2 Patients
- (2014) Lena Grüber et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
- (2013) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
- (2013) Masahiro Nitta et al. SCHIZOPHRENIA BULLETIN
- Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders
- (2013) Michael E. Benros et al. JAMA Psychiatry
- Autoimmune diseases and infections as risk factors for schizophrenia
- (2012) Michael E. Benros et al. Annals of the New York Academy of Sciences
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
- (2012) Seyed-Hesameddin Abbasi et al. JOURNAL OF AFFECTIVE DISORDERS
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register Study
- (2011) Michael E. Benros et al. AMERICAN JOURNAL OF PSYCHIATRY
- Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia
- (2011) Iris E. Sommer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders
- (2010) Wijnand Laan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
- (2009) Shahin Akhondzadeh et al. DEPRESSION AND ANXIETY
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
- (2008) Fabiano G. Nery et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Unknown
- (2008) Martin Begemann et al. MOLECULAR MEDICINE
- Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia
- (2008) H. J. Sorensen et al. SCHIZOPHRENIA BULLETIN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started